We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Sopheon Plc | LSE:SPE | London | Ordinary Share | GB00BSZM1369 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 990.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/6/2017 14:06 | Just bought at this cheap crazy price.... | ragewarrior | |
12/6/2017 08:04 | Just read the Finncap note. To 31/12/18 earnings expected 31p Net cash 99p. Multiple of 12x plus cash = 471p. Sector valuation of 15x plus cash = 564p At least 25% undervalued. | elsa7878 | |
09/6/2017 11:14 | Every little helps. British Bulls Signal Update 08/06/2017: “Our system’s recommendation today is to BUY. The BULLISH HARAMI pattern finally received a confirmation because the prices crossed above the confirmation level which was at 378.7500, and our valid average buying price stands now at 379.2500. “… | odys2 | |
08/6/2017 19:12 | That's good. Thanks Rage | gswredland | |
08/6/2017 14:13 | Today's broker update 08/06 finnCap Reiterates 620p.. | ragewarrior | |
08/6/2017 12:27 | If I've got my maths right this is trading somewhere at or below 2.0x 2016 revenue, including dilution and cash. Forward multiple even lower. Seems a little undervalued for a growing and profitable software firm that also offers SaaS. Fair enough not explosive growth, and not the best sector (PLM), but still. Market seems to have split personality when it comes to tech stock ... | mairw | |
08/6/2017 10:36 | positive trading statement yet understated at the same time. no unexpected negativity which may have been behind the recent share price decline. IMHO. | mfhmfh | |
08/6/2017 08:35 | MM's playing the game this morning looking for cheap stock - Lots of buys being pushed through as sells so far. This is a quality company locking in customers for the long-term, buy and hold and the benefits will come. | tallprawn | |
08/6/2017 08:22 | On fundamentals - it should be at least 20% above here. Let the weak holders out and pick up the stock cheap. | elsa7878 | |
08/6/2017 08:08 | not quite the share price reaction I expected. | janeann | |
08/6/2017 07:43 | Always under stating and always over delivering. A solid investment for me. I expect broker notes to confirm or increase targets. All we need now is a dividend policy. | chadders | |
08/6/2017 07:42 | Allowing for the fact that they will not be paying any tax for the next few years, they should be achieving profits of at least £2.5 million a year. Factor in net assets of £8 million and at £27 million this is cheap. | elsa7878 | |
08/6/2017 07:36 | Its good to see the forward revenue is ahead of last year even though last year included one exceptional large contract. The Sopheon offering is therefore appealing to a more varied and widespread client base with a greater chance of further uptake later in the year. More industry recognition also by Gartner which wont do any harm. | bahiflyer | |
08/6/2017 07:22 | What's good about this company is the NEW customers coming onboard and the existing ones staying..... | ragewarrior | |
08/6/2017 07:17 | Looks pretty decent to me; It gives us great pleasure to report another year of excellent financial and operational progress, as we continue to advance our strategy of being the world's leading solution provider of enterprise-class innovation management software solutions. A year ago we were pleased to report solid strategic and financial progress, and we are delighted to say the same applies today, one year later. Last year we grew revenues to $23.2m from $20.9m in 2015 and $18.3m in 2014, and we delivered another substantial increase in profitability, with EBITDA rising to $5.2m before exchange gains ($5.6m including exchange gains) from $4.1m the year before, which was itself more than triple the 2014 performance. Profit before tax rose to $3.0m from $1.2m in 2015. In 2016 we also initiated partial recognition of our substantial deferred tax asset, which resulted in a profit after tax of $4.3m. Net assets nearly doubled to $10.4m from $5.5m in 2015. The revenue growth was underpinned by a rise to 49 license transactions from 42 the year before, of which 17 were new customers, up from 14 in 2015. We continued to invest in and show traction with the two elements of our go-to-market strategy - both the global end-to-end enterprise solution, and the "out-of-the-box" Accolade Express solution for quicker time to value. Our market strength in the consumer products industry was again recognized, with Sopheon being voted a "top ten software vendor" for the seventh consecutive year by the CGT magazine readership. In addition to this progress, we also saw strong traction in the aerospace and defense and chemicals sectors. Sopheon's commercial success is being achieved in parallel with strategic and operational initiatives aimed at underpinning our continued growth for the next three to five years. We maintained our rapid pace of product development releases, with another three in 2016, further advancing our platform for enterprise utilization and flexibility, followed by version 11.1 which we released in February this year. This continued investment supports our growth strategy in two areas. One is to capitalize on existing client demand to expand their Accolade investment beyond product innovation to support Enterprise Initiative Management tracking and decision making. This market opportunity has been validated by Gartner's 2016 Market Guide for Strategy Execution Software and their recognition of Sopheon in this emerging space. We are also delighted to announce Sopheon's inclusion in Gartner's Magic Quadrant for Project Portfolio Management, just last week. Sopheon is the only vendor referenced in both the Market Guide for Strategy Execution Software and the Magic Quadrant for Project Portfolio Management. In Sopheon's view, this provides strong validation of our unique position and strength in the enterprise portfolio management, enterprise initiative management, and product development markets. The second growth area we continue to invest in is our vertical industry focus on chemical, consumer goods, food and beverage, aerospace and defense, and high-tech. In addition, we are researching the insurance, service and automobile industries as we have recently signed customers in these areas. Such customers help us to understand the value proposition Accolade can bring to new vertical markets, and to determine if these represent further new growth opportunities for the Company. Following several years of clarifying our debt, equity and listing structure, our corporate activity has been relatively quiet in the past year, other than extension of the maturity of our debt facilities to January 2019. Sopheon has a market-leading solution, global reach, solid financials, a clear corporate structure, an accelerating market, and most importantly great people - a real platform for growth. Full year revenue visibility for 2017 from contracted business and recurring revenue streams is now at $17.5m, compared to just under $17.0m at this time last year. This includes 20 license orders, up from 14 for the same period last year. This is a different mix compared to this time last year, which included a very substantial order from an existing enterprise tier customer. This is further evidence of the increased adoption of the Company's software and services from a broader range of businesses, including several with expected upside revenue later this year. Sopheon also continues its focus on working with and growing relationships with global blue chip customers such as Electrolux, PepsiCo, Proctor & Gamble and Merck. These factors, together with a strong sales pipeline, give the Board confidence in meeting our strategic and financial plans for the year, and in delivering continued positive development in our performance for 2017 and beyond. | janeann | |
07/6/2017 12:52 | I reckon the shareholder that converted their loan into 65,000 shares is probably selling them. They were admitted to trading on the 2nd and so they are still probably being drip fed in. Looking back over the last 6 months of statements, I can see no reason why the statement tomorrow should be anything but positive. | elsa7878 | |
07/6/2017 11:31 | You can by 10000 shares or 37k worth well within the spread 364 | esther1975 | |
07/6/2017 11:23 | But there many sellers?? | trinko | |
07/6/2017 11:09 | Just bought back into these @ 364.80 should be some good updates from the AGM, this is still a growing company... | ragewarrior | |
07/6/2017 09:20 | I'm struggling to see why this has retraced again this week prior to the AGM update other than nervous sellers bailing. It's worth noting that Barry Mence purchased on the 7th April at 443p. That's a strong buy signal for me - I'm expecting a positive statement this week and a bounce back towards 500p levels from here.Top-up for me - GL all and DYOR. | tallprawn | |
06/6/2017 08:52 | Mikeh30 - yes thanks, the 65,359 was the exact figure granted. Half of loans I understand are not held by the small group of insiders we know about. If anyone is going to AGM please let me know. | samsj | |
05/6/2017 18:35 | 10mill in cash and growing. 500p + target. | mikeh30 | |
05/6/2017 15:59 | Fingers crossed - let's see | gswredland | |
05/6/2017 12:10 | buyers rocking in | larva |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions